Design Therapeutics (DSGN) had the highest return on April 29 by a small-cap US stock, returning 21.5%.

ASSET	DATE	% RETURN
Design Therapeutics (DSGN)	4/29/2026	21.46%
SL Science Holding Limited Ordinary Shares (SLBT)	4/29/2026	20.6%
FuelCell Energy (FCEL)	4/29/2026	19.65%
First Tracks Biotherapeutics (TRAX)	4/29/2026	19.27%
Adlai Nortye Ltd American Depositary Shares (ANL)	4/29/2026	16.74%
TJGC (TJGC)	4/29/2026	15.02%
Korsana Biosciences (KRSA)	4/29/2026	12.16%
PROG (PRG)	4/29/2026	10.69%
Nabors Industries (NBR)	4/29/2026	10.65%
W&T Offshore (WTI)	4/29/2026	10.35%
Elmet Group Co Common Stock (ELMT)	4/29/2026	8.8%
Ring Energy (REI)	4/29/2026	8.77%
Plug Power (PLUG)	4/29/2026	8.6%
Eikon Therapeutics, Inc Common Stock (EIKN)	4/29/2026	8.58%
CEVA (CEVA)	4/29/2026	8.53%
Oncology Institute (STLN)	4/29/2026	8.16%
MMTEC (MTC)	4/29/2026	7.94%
Daqo New Energy Corp ADR (DQ)	4/29/2026	7.56%
Angel Studios (ANGX)	4/29/2026	7.11%
XMax (XMAX)	4/29/2026	6.91%
Evolent Health (EVH)	4/29/2026	6.46%
SharonAI Holdings, Inc Class A Common Stock (SHAZ)	4/29/2026	6.46%
O-I Glass (OI)	4/29/2026	6.13%
Sophia Genetics (SOPH)	4/29/2026	5.81%
Vistance Networks (VISN)	4/29/2026	5.76%

Small-cap stocks are treated as having a market cap between $300M and $2B.